tiprankstipranks
Greenwich LifeSciences (GLSI)
NASDAQ:GLSI
US Market

Greenwich LifeSciences (GLSI) Financial Statements

358 Followers

Greenwich LifeSciences Financial Overview

Greenwich LifeSciences's market cap is currently ―. The company's EPS TTM is $-0.719; its P/E ratio is -20.63; Greenwich LifeSciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -2.47M$ -2.75M$ -2.39M$ -1.63M$ 2.24M
EBITDA$ -2.47M$ -2.75M$ -2.39M$ -1.63M$ 2.24M
Net Income Common Stockholders$ -2.47M$ -2.75M$ -2.39M$ -1.63M$ 2.36M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 5.51M$ 6.99M$ 9.14M$ 10.94M$ 11.91M
Total Assets$ 5.51M$ 6.99M$ 9.15M$ 10.95M$ 11.92M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -5.51M$ -6.99M$ -9.14M$ -10.94M$ -11.91M
Total Liabilities$ 389.61K$ 294.41K$ 297.29K$ 301.55K$ 235.57K
Stockholders Equity$ 5.12M$ 6.70M$ 8.85M$ 10.65M$ 11.68M
Cash Flow-
Free Cash Flow$ -1.78M$ -2.15M$ -1.80M$ -966.98K$ -1.56M
Operating Cash Flow$ -1.78M$ -2.15M$ -1.80M$ -966.98K$ -1.56M
Investing Cash Flow-----
Financing Cash Flow$ 299.12K----
Currency in USD

Greenwich LifeSciences Earnings and Revenue History

Greenwich LifeSciences Debt to Assets

Greenwich LifeSciences Cash Flow

Greenwich LifeSciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis